Global Anti-obesity Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-obesity Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-obesity Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-obesity Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti-obesity Drugs Segment by Type

2.2.1 Peripherally Acting Anti-obesity Drugs

2.2.2 Centrally Acting Anti-obesity Drugs

2.3 Anti-obesity Drugs Sales by Type

2.3.1 Global Anti-obesity Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-obesity Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-obesity Drugs Sale Price by Type (2017-2022)

2.4 Anti-obesity Drugs Segment by Application

2.4.1 Kids

2.4.2 Adults

2.5 Anti-obesity Drugs Sales by Application

2.5.1 Global Anti-obesity Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-obesity Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-obesity Drugs Sale Price by Application (2017-2022)

3 Global Anti-obesity Drugs by Company

3.1 Global Anti-obesity Drugs Breakdown Data by Company

3.1.1 Global Anti-obesity Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti-obesity Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti-obesity Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-obesity Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti-obesity Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti-obesity Drugs Sale Price by Company

3.4 Key Manufacturers Anti-obesity Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-obesity Drugs Product Location Distribution

3.4.2 Players Anti-obesity Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-obesity Drugs by Geographic Region

4.1 World Historic Anti-obesity Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-obesity Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-obesity Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti-obesity Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-obesity Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-obesity Drugs Annual Revenue by Country/Region

4.3 Americas Anti-obesity Drugs Sales Growth

4.4 APAC Anti-obesity Drugs Sales Growth

4.5 Europe Anti-obesity Drugs Sales Growth

4.6 Middle East & Africa Anti-obesity Drugs Sales Growth

5 Americas

5.1 Americas Anti-obesity Drugs Sales by Country

5.1.1 Americas Anti-obesity Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti-obesity Drugs Revenue by Country (2017-2022)

5.2 Americas Anti-obesity Drugs Sales by Type

5.3 Americas Anti-obesity Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-obesity Drugs Sales by Region

6.1.1 APAC Anti-obesity Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti-obesity Drugs Revenue by Region (2017-2022)

6.2 APAC Anti-obesity Drugs Sales by Type

6.3 APAC Anti-obesity Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-obesity Drugs by Country

7.1.1 Europe Anti-obesity Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti-obesity Drugs Revenue by Country (2017-2022)

7.2 Europe Anti-obesity Drugs Sales by Type

7.3 Europe Anti-obesity Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-obesity Drugs by Country

8.1.1 Middle East & Africa Anti-obesity Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-obesity Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-obesity Drugs Sales by Type

8.3 Middle East & Africa Anti-obesity Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-obesity Drugs

10.3 Manufacturing Process Analysis of Anti-obesity Drugs

10.4 Industry Chain Structure of Anti-obesity Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-obesity Drugs Distributors

11.3 Anti-obesity Drugs Customer

12 World Forecast Review for Anti-obesity Drugs by Geographic Region

12.1 Global Anti-obesity Drugs Market Size Forecast by Region

12.1.1 Global Anti-obesity Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti-obesity Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-obesity Drugs Forecast by Type

12.7 Global Anti-obesity Drugs Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck Anti-obesity Drugs Product Offered

13.1.3 Merck Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Novo Nordisk

13.2.1 Novo Nordisk Company Information

13.2.2 Novo Nordisk Anti-obesity Drugs Product Offered

13.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novo Nordisk Main Business Overview

13.2.5 Novo Nordisk Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Anti-obesity Drugs Product Offered

13.3.3 Pfizer Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Arena Pharmaceuticals

13.4.1 Arena Pharmaceuticals Company Information

13.4.2 Arena Pharmaceuticals Anti-obesity Drugs Product Offered

13.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Arena Pharmaceuticals Main Business Overview

13.4.5 Arena Pharmaceuticals Latest Developments

13.5 Roche

13.5.1 Roche Company Information

13.5.2 Roche Anti-obesity Drugs Product Offered

13.5.3 Roche Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Roche Main Business Overview

13.5.5 Roche Latest Developments

13.6 GlaxoSmithKline

13.6.1 GlaxoSmithKline Company Information

13.6.2 GlaxoSmithKline Anti-obesity Drugs Product Offered

13.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GlaxoSmithKline Main Business Overview

13.6.5 GlaxoSmithKline Latest Developments

13.7 Orexigen Therapeutics

13.7.1 Orexigen Therapeutics Company Information

13.7.2 Orexigen Therapeutics Anti-obesity Drugs Product Offered

13.7.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Orexigen Therapeutics Main Business Overview

13.7.5 Orexigen Therapeutics Latest Developments

13.8 Vivus

13.8.1 Vivus Company Information

13.8.2 Vivus Anti-obesity Drugs Product Offered

13.8.3 Vivus Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Vivus Main Business Overview

13.8.5 Vivus Latest Developments

13.9 Amylin

13.9.1 Amylin Company Information

13.9.2 Amylin Anti-obesity Drugs Product Offered

13.9.3 Amylin Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Amylin Main Business Overview

13.9.5 Amylin Latest Developments

13.10 Alizyme

13.10.1 Alizyme Company Information

13.10.2 Alizyme Anti-obesity Drugs Product Offered

13.10.3 Alizyme Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Alizyme Main Business Overview

13.10.5 Alizyme Latest Developments

13.11 Boehringer Ingelheim

13.11.1 Boehringer Ingelheim Company Information

13.11.2 Boehringer Ingelheim Anti-obesity Drugs Product Offered

13.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Boehringer Ingelheim Main Business Overview

13.11.5 Boehringer Ingelheim Latest Developments

13.12 Eisai

13.12.1 Eisai Company Information

13.12.2 Eisai Anti-obesity Drugs Product Offered

13.12.3 Eisai Anti-obesity Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Eisai Main Business Overview

13.12.5 Eisai Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-obesity Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-obesity Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Peripherally Acting Anti-obesity Drugs

Table 4. Major Players of Centrally Acting Anti-obesity Drugs

Table 5. Global Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Anti-obesity Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Anti-obesity Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-obesity Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-obesity Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Anti-obesity Drugs Revenue by Application (2017-2022)

Table 13. Global Anti-obesity Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-obesity Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Anti-obesity Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Anti-obesity Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Anti-obesity Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-obesity Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-obesity Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Anti-obesity Drugs Producing Area Distribution and Sales Area

Table 21. Players Anti-obesity Drugs Products Offered

Table 22. Anti-obesity Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-obesity Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Anti-obesity Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-obesity Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-obesity Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-obesity Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Anti-obesity Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-obesity Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-obesity Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Anti-obesity Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-obesity Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Anti-obesity Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Anti-obesity Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-obesity Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-obesity Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Anti-obesity Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Anti-obesity Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-obesity Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Anti-obesity Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Anti-obesity Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-obesity Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-obesity Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Anti-obesity Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-obesity Drugs

Table 66. Key Market Challenges & Risks of Anti-obesity Drugs

Table 67. Key Industry Trends of Anti-obesity Drugs

Table 68. Anti-obesity Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-obesity Drugs Distributors List

Table 71. Anti-obesity Drugs Customer List

Table 72. Global Anti-obesity Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Anti-obesity Drugs Sales Market Forecast by Region

Table 74. Global Anti-obesity Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-obesity Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Anti-obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-obesity Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Anti-obesity Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Anti-obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-obesity Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Anti-obesity Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-obesity Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Anti-obesity Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-obesity Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-obesity Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-obesity Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Anti-obesity Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-obesity Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-obesity Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merck Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Merck Anti-obesity Drugs Product Offered

Table 94. Merck Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Merck Main Business

Table 96. Merck Latest Developments

Table 97. Novo Nordisk Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Novo Nordisk Anti-obesity Drugs Product Offered

Table 99. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Novo Nordisk Main Business

Table 101. Novo Nordisk Latest Developments

Table 102. Pfizer Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Pfizer Anti-obesity Drugs Product Offered

Table 104. Pfizer Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Pfizer Main Business

Table 106. Pfizer Latest Developments

Table 107. Arena Pharmaceuticals Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Arena Pharmaceuticals Anti-obesity Drugs Product Offered

Table 109. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Arena Pharmaceuticals Main Business

Table 111. Arena Pharmaceuticals Latest Developments

Table 112. Roche Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Roche Anti-obesity Drugs Product Offered

Table 114. Roche Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Roche Main Business

Table 116. Roche Latest Developments

Table 117. GlaxoSmithKline Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. GlaxoSmithKline Anti-obesity Drugs Product Offered

Table 119. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. GlaxoSmithKline Main Business

Table 121. GlaxoSmithKline Latest Developments

Table 122. Orexigen Therapeutics Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Orexigen Therapeutics Anti-obesity Drugs Product Offered

Table 124. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Orexigen Therapeutics Main Business

Table 126. Orexigen Therapeutics Latest Developments

Table 127. Vivus Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Vivus Anti-obesity Drugs Product Offered

Table 129. Vivus Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Vivus Main Business

Table 131. Vivus Latest Developments

Table 132. Amylin Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Amylin Anti-obesity Drugs Product Offered

Table 134. Amylin Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Amylin Main Business

Table 136. Amylin Latest Developments

Table 137. Alizyme Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Alizyme Anti-obesity Drugs Product Offered

Table 139. Alizyme Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Alizyme Main Business

Table 141. Alizyme Latest Developments

Table 142. Boehringer Ingelheim Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Boehringer Ingelheim Anti-obesity Drugs Product Offered

Table 144. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Boehringer Ingelheim Main Business

Table 146. Boehringer Ingelheim Latest Developments

Table 147. Eisai Basic Information, Anti-obesity Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Eisai Anti-obesity Drugs Product Offered

Table 149. Eisai Anti-obesity Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Eisai Main Business

Table 151. Eisai Latest Developments

List of Figures

Figure 1. Picture of Anti-obesity Drugs

Figure 2. Anti-obesity Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-obesity Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-obesity Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-obesity Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Peripherally Acting Anti-obesity Drugs

Figure 10. Product Picture of Centrally Acting Anti-obesity Drugs

Figure 11. Global Anti-obesity Drugs Sales Market Share by Type in 2021

Figure 12. Global Anti-obesity Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Anti-obesity Drugs Consumed in Kids

Figure 14. Global Anti-obesity Drugs Market: Kids (2017-2022) & (K Units)

Figure 15. Anti-obesity Drugs Consumed in Adults

Figure 16. Global Anti-obesity Drugs Market: Adults (2017-2022) & (K Units)

Figure 17. Global Anti-obesity Drugs Sales Market Share by Application (2017-2022)

Figure 18. Global Anti-obesity Drugs Revenue Market Share by Application in 2021

Figure 19. Anti-obesity Drugs Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Anti-obesity Drugs Revenue Market Share by Company in 2021

Figure 21. Global Anti-obesity Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Anti-obesity Drugs Revenue Market Share by Geographic Region in 2021

Figure 23. Global Anti-obesity Drugs Sales Market Share by Region (2017-2022)

Figure 24. Global Anti-obesity Drugs Revenue Market Share by Country/Region in 2021

Figure 25. Americas Anti-obesity Drugs Sales 2017-2022 (K Units)

Figure 26. Americas Anti-obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 27. APAC Anti-obesity Drugs Sales 2017-2022 (K Units)

Figure 28. APAC Anti-obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 29. Europe Anti-obesity Drugs Sales 2017-2022 (K Units)

Figure 30. Europe Anti-obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Anti-obesity Drugs Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Anti-obesity Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Americas Anti-obesity Drugs Sales Market Share by Country in 2021

Figure 34. Americas Anti-obesity Drugs Revenue Market Share by Country in 2021

Figure 35. United States Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Anti-obesity Drugs Sales Market Share by Region in 2021

Figure 40. APAC Anti-obesity Drugs Revenue Market Share by Regions in 2021

Figure 41. China Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Anti-obesity Drugs Sales Market Share by Country in 2021

Figure 48. Europe Anti-obesity Drugs Revenue Market Share by Country in 2021

Figure 49. Germany Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Anti-obesity Drugs Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Anti-obesity Drugs Revenue Market Share by Country in 2021

Figure 56. Egypt Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Anti-obesity Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Anti-obesity Drugs in 2021

Figure 62. Manufacturing Process Analysis of Anti-obesity Drugs

Figure 63. Industry Chain Structure of Anti-obesity Drugs

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles